The COVID-19 virus and subsequent lockdown has been the catalyst for the long-awaited digital transformation of the pharmaceutical industry, forcing an unprecedented shift in the way we communicate with key stakeholders. However, as fast as it feels, we may not be going as far or as fast as we nOriginal Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.